跳至主要内容
临床试验/NCT00999973
NCT00999973Unknown1 期

Study on the Effect of Mitomycin C 0.02% on the Corneal Endothelial After Photorefractive Keratectomy in Moderate Myopia

Shahid Beheshti University of Medical Sciences1 个研究点 分布在 1 个国家开始时间: 2009年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
试验地点
1

研究概览

简要总结

In this study 126 eyes in 63 patients with moderate bilateral myopia and astigmatism between -3 and -5 (SE difference between two eyes should not be more than 0.75 and the residual corneal thickness>350 μ ) were entered in the study. One eye went randomly under PRK with mitomycin C 0.02% in 15 min and then the other eye went under the operation without MMC. UCVA,BCVA, refractory error after the operation and the number of endothelial cells before and after the surgery would be compared in 6 months.

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 19 < age < 60
  • Refractory error stabled for at least one year
  • No corneal pathology
  • -3 < bilateral myopia and astigmatism < -5 with no difference more than 0.75 between 2 eyes
  • Exclusion criteria:
  • Keratoconus
  • Ectatic corneal disease
  • Corneal dystrophy
  • Lens changes affecting the visual acuity
  • Anterior or posterior uveitis
  • Corneal scar

排除标准

  • 未提供

研究组 & 干预措施

Mitomycin c 0.02%

Active Comparator

干预措施: Mitomycin C 0.02% (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

研究者

研究点 (1)

Loading locations...

相似试验